{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:11:50Z","timestamp":1778188310497,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.dmd.2026.100255","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:11:08Z","timestamp":1771978268000},"page":"100255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-5336","authenticated-orcid":false,"given":"Rucha S.","family":"Sane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-3544","authenticated-orcid":false,"given":"Pallabi","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-333X","authenticated-orcid":false,"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Yanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6097-2651","authenticated-orcid":false,"given":"Chester","family":"Costales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Salphati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Mahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.J.","family":"Bow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1362-2368","authenticated-orcid":false,"given":"James M.","family":"Vergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-038X","authenticated-orcid":false,"given":"Jochen","family":"Brumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Taskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-9813","authenticated-orcid":false,"given":"Hugues","family":"Chanteux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7985-3549","authenticated-orcid":false,"given":"Zhizhou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0547-2247","authenticated-orcid":false,"given":"Imad","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilay","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8287-6878","authenticated-orcid":false,"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-6442","authenticated-orcid":false,"given":"Helen E.","family":"Rollison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0300-726X","authenticated-orcid":false,"given":"Mitchell E.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1284-2769","authenticated-orcid":false,"given":"Emi","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine S.","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Hillgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dmd.2026.100255_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.dmd.2026.100255_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.dmd.2026.100255_bib3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in drug development: 2018 ITC recommendations","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100255_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/cpt.1214","article-title":"Transporters in drug development: scientific and regulatory considerations","volume":"104","author":"Zhang","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dmd.2026.100255_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/dmd.123.001587","article-title":"Survey of pharmaceutical industry best practices around in vitro transporter assessment","volume":"52","author":"Rollison","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2026.100255_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejps.2010.03.023","article-title":"Screening of OATP1B1\/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension","volume":"40","author":"Badolo","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.dmd.2026.100255_bib7","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.dmd.2026.100255_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2015.01.004","article-title":"Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1\u221715 and OATP1B3","volume":"70","author":"van de Steeg","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.dmd.2026.100255_bib9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/acs.jcim.8b00466","article-title":"Integrative data mining, Scaffold analysis, and sequential binary classification models for exploring ligand profiles of hepatic organic anion transporting polypeptides","volume":"59","author":"Turkova","year":"2019","journal-title":"J Chem Inf Model"},{"issue":"11","key":"10.1016\/j.dmd.2026.100255_bib10","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/acs.molpharmaceut.2c00662","article-title":"Machine learning models identify new inhibitors for human OATP1B1","volume":"19","author":"Lane","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.dmd.2026.100255_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106362","article-title":"Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs","volume":"181","author":"Deng","year":"2023","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100255_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12031-007-0055-y","article-title":"The role of size and charge for blood-brain barrier permeation","volume":"33","author":"Seelig","year":"2007","journal-title":"J Mol Neurosci"},{"issue":"6","key":"10.1016\/j.dmd.2026.100255_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/mol.112.084152","article-title":"Structure-based identification of OATP1B1\/3 inhibitors","volume":"83","author":"De Bruyn","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100255_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100255_bib15","series-title":"Certara DDI Database (former University of Washington DDI Database)","year":"2022"},{"issue":"11","key":"10.1016\/j.dmd.2026.100255_bib16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1124\/dmd.118.081307","article-title":"When does the rate-determining step in the hepatic clearance of a drug switch from sinusoidal uptake to all hepatobiliary clearances? Implications for Predicting Drug-Drug Interactions","volume":"46","author":"Patilea-Vrana","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2026.100255_bib17","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: ECCS","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100255_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cpt.1072","article-title":"Cytochrome P450 3A induction predicts P-glycoprotein induction; part 2: prediction of decreased substrate exposure after rifabutin or carbamazepine","volume":"104","author":"Lutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100255_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cpt.2510","article-title":"Acute and chronic effects of rifampin on letermovir","volume":"111","author":"Robbins","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dmd.2026.100255_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.119.088922","article-title":"Organic anion-transporting polypeptide genes are not induced by the pregnane X receptor activator rifampin","volume":"47","author":"Niu","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100255_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.119.089615","article-title":"Induction of human intestinal and hepatic OATPs","volume":"48","author":"Rodrigues","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100255_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cpt.1916","article-title":"Intestinal P-gp and putative hepatic OATP1B induction","volume":"109","author":"Zamek-Gliszczynski","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmd.2026.100255_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/cpt.2089","article-title":"Drug-drug interactions involving renal OCT2\/MATE transporters: clinical risk assessment may require endogenous biomarker-informed approach","volume":"110","author":"Mathialagan","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100255_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cpt.2022","article-title":"Identification of appropriate endogenous biomarker for risk assessment of multidrug and toxin extrusion protein-mediated drug-drug interactions in healthy volunteers","volume":"109","author":"Miyake","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100255_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/psp4.12610","article-title":"Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1\/3 renal transporters","volume":"10","author":"Ahmad","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100255_bib26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/dmd.121.000486","article-title":"Endogenous plasma kynurenic acid as biomarker for OAT1\/3 inhibition","volume":"49","author":"Tang","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100255_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40262-021-01004-2","article-title":"Clinical investigation on endogenous biomarkers for OAT DDIs","volume":"60","author":"Willemin","year":"2021","journal-title":"Clin Pharmacokinet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:44:21Z","timestamp":1778186661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0090955626000243"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100255","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100255"}}